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The effects of three oral dosages (0.4 mg, 0.8 mg, and 1.6 mg) of quercetin on
Colon-25 tumors implanted in Balb-c mice were studied.  The data in this study show
that: (1) certain dosages of quercetin in alcohol solutions, reduces the weight, and size of
implanted Colon-25 tumors in Balb-c mice, (2) these same dosages of quercetin all
produce a profound neutrophilia combined with a significant lymphopenia at day 20 post-
implantation, and (3) there was relatively little evidence of histological changes in the
quercetin-treated tumor section which would indicate that the action(s) of quercetin is
primarily at the subcellular level probably within the nuclei of the tumor cells.
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In his text, Boik (1995) reviewed the reported biological actions of a certain group
of natural substances called bioflavonoids of which quercetin is a member.  Research on
these flavonoids began in the 1930s in the laboratory of Szent-Gyorgyi, the discoverer of
vitamin C (Bruckner and Szent-Gyorgyi 1936).  They are found in a variety of foods
(citrus fruits, vegetables) as well as beverages (coffee, tea, wine).  Boik divided the
flavonoids into five categories (anthocyanins, minor flavonoids, flavones or flavonoids,
isoflavonoids, and tannins).  Quercetin is a member of the flavones group that are thought
to be the most widely distributed.  Over the past 60 years, bioflavonoids have been
reported to be involved in several important biological processes including: (1)
antiallergic reactions (2) immunological modulation (3) the clotting sequence involving
platelet aggregation and (4) antitumor actions.
This study was based on the reported antitumor properties of quercetin that
include: lymphocyte proliferation (Pignol et al. 1988), neutrophilia (Musiani et al. 1996),
free radical scavenging (Affany et al. 1987), angiogenesis (Teicher et al. 1991), the
mitotic cycle in tumor cells (Yoshida et al. 1990), altering gene expression (Kioka et al.
1992), and inducing the phenomenon of cell suicide (apoptosis) in cells (Indap et al.
1997).
Most of the work done with quercetin has been concerned with its effects on
various cancer cell cultures in vitro.  The literature is relatively sparse with data from the
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in vivo experiments involving intact, solid tumors in mammals under controlled
laboratory conditions.
The general aim of this study, therefore, was to measure the effects of varying
dosages of quercetin injected over a controlled time period on the growth of implanted
Colon-25 tumor brei in immunodeficient Balb-c mice.
The specific parameters that were measured included: (1) changes in growth rate
(2) tumor size and weight (3) tumor histology and (4) leucocyte differential count in the
mice.
The data obtained in this study should provide information on the feasibility of




Twenty-five male and twenty-five female mice, ranging in weight (16-27g) and
age (2-4 months) were bred at the University of North Texas Animal Care Facility.  They
were implanted with a 4mm x 4mm medullary section (brei) of a human Colon-25 tumor
from a donor mouse.  Implanted sections were measured using a Petri dish with a piece of
1mm x 1mm graph paper attached underneath (see Figure 1A).  Excised tumors were first
placed in a Ringers solution to insure their viability after their removal from the donor
mouse.  The moistened 4mm x 4mm section was then injected between the iliac crest and
the ribcage posteriorly below the epidermis using a 13 gauge needle.  This strain of mice
was used because of its reduced immune system, thereby facilitating the growth of
implanted tumor brei into solid tumors within days.
The mice were maintained at the University of North Texas Animal Care Facility
in a temperature regulated room and on 12 hour light-dark cycle.  They were given water
ad libitum, and fed a diet of Teklad rodent pellets.
The quercetin was donated by Thorne Industries (P.O. Box 25 Dover, Idaho
83825), and was analyzed for its purity by Freeman Industries (100 Marbledale Road
Tuckahoe, New York 10707-0415).
Formulation of the Test Solutions
  One gram of quercetin was combined with 312.5 ml of ethyl alcohol resulting in
a stock solution with a concentration of 3.2 mg/ml.  This concentration is the published
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LD50 for a 20g mouse (Stecher et al. 1960).  The stock solution was diluted with distilled
water prior to injection to avoid precipitation of quercetin.  For the 1.6 mg/ml dilution,
stock solution and distilled water were mixed in equal parts.  The 1.6 mg/ml solution was
again mixed with equal parts of distilled water to produce a 0.8mg/ml dilution.  Finally,
the 0.8mg/ml solution was mixed with equal parts of distilled water to produce a
0.4mg/ml dilution.  This solution was administered orally five times per week (Monday-
Friday) using a one ml plastic tipped pipette.  The daily injections were given at or before
noon, and measurements of the tumor using calipers (Figure 1B) commenced when the
tumor could first be palpated (usually 7 days post-implantation).  The quercetin injections
were begun on the first day of palpitation and ceased on day 20 post-implantation.  At
this time, the mouse was euthanized by cervical dislocation, and the tumor was excised
and placed in a 2% formalin solution.
The mice were divided into control and test groups as follows:
I. Control
A. Sham control animals received 1ml of distilled water (5 males and 5 females)
B. Control animals received 0.5ml of 98% ethyl alcohol in 0.5ml of distilled
water (5 males and 5 females)
II. Test animals (Quercetin)
A. 1.6mg quercetin (5 male and 5 female mice)
B. 0.8mg quercetin (5 male and 5 female mice)
C. 0.4mg quercetin (5 male and 5 female mice)
5
The parameters examined were: (1) daily changes in tumor size (length x width),
(2) changes in blood leukocyte differential count using Diff-Quick differential stains,  (3)
changes in autopsied tumor weights (grams),  (4) changes in autopsied tumor histology.
The tumors were measured daily Monday thru Friday following the first day of
physical palpitation of the tumor.  On the 20th day of post-implantation, the tumors were
removed, weighed, and placed in a 2% formalin solution.  Each tumor was then
embedded in paraffin and sectioned using a 820 Spencer microtome (Buffalo, New York)
into 16-20 µm sections.  The sections were then stained using Harris Hematoxylin 3 and
eosin, and photomicrographs were taken using a Zeiss microscope fitted with a 35mm
Olympus camera loaded with Kodak Ektachrome Elite 200 exposure 35mm film.
Students two-tail t-test was used to test the statistical significance of the data.
This study was approved by the Institutional Animal Care and Use Committee at the
University of North Texas.
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                        A. Petri dish with 1mm x 1mm grid       B. Mechanical calipers cm/inches




The data obtained in this study are presented in the form of time-course-curves in
Figures showing daily changes in tumor size which are summarized in Tables.  The data
were statistically analyzed using Students two tailed T-test.  Photographs of an
encapsulated tumor in situ and an excised decapsulated tumor are shown in Figure 2A.
Photomicrographs of medullary sections of tumors from animals treated with varying
dosages of quercetin were compared with those from non-treated tumors.
A typical encapsulated tumor in situ is shown in Figure 2A.  The tumor is solid,
well defined, and relatively symmetrical.  Since the tumors were implanted in the back
along the spine between the ribcage and the pelvis, they all showed growth posterior to
the site of implantation.  Figure 2B shows a typical excised tumor at day 20 post-
implantation.  At autopsy, there were no signs of metastasis in the thoracic and abdominal
regions.
The data in Figure 3 compare the growth rate of tumors in mice injected with
either water (sham-controls) or alcohol alone (solvent controls).  No statistically
significant differences were noted in the tumor growth rate between the alcohol and the
water-injected mice.  This was confirmed by comparing the slopes of the time course
growth curves seen in Figure 3 and Table 1.  Moreover, there were no significant
differences in the tumor growth rates between the male and female animals.
As shown in Figure 4 daily dosages of 0.4mg/ml quercetin brought about a
decrease in the tumor growth rates in both male and female mice.  Tumor growth rates of
8
 A. Encapsulated tumor in situ
B. Excised decapsulated tumor
Figure 2 Colon-25 autopsied tumors from Balb-c mice at 20 days post-implantation
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Figure 3  Effects of daily oral injections of alcohol and water on mean growth
rates of implanted Colon-25 tumors in Balb-c mice.  Day 7 represents initial time









































                Length x Width
n Dosage cm2 SEM %∆
5 Water Control 2.84 0.65 0%
5 Alcohol-sham 2.81 0.60 -1%
A. Females
                Length x Width
n Dosage cm2 SEM %∆
5 Water Control 2.99 0.56 0%
5 Alcohol-sham 2.87 0.54 -4%
 %∆ = T - C x 100
C 
Statistical significance determined by a two tailed T test
Table 1   Summary of the effects of oral injections of water  
and alcohol on mean size of implanted Colon-25 
tumors in Balb-c mice.
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females were slightly higher than in males.
Figure 5 shows the mean growth rates of tumors in males (Figure 5A) and females
(Figure 5B) treated with 0.8mg/ml of quercetin.  Again, the tumors grew at a slower rate
in both the treated male and female mice; growth of the tumors was slower in the males.
The mean tumor growth rates, of male and female mice treated with 1.6mg/ml, are
depicted in Figures 6A and 6B respectively.  The abrupt drop in the growth curve in
Figure 6A at day 18, was due to the death of a male mouse.  A similar drop is evident in
Figure 6B at day 14, when a female mouse died prematurely.
The effects of quercetin on Colon-25 mean tumor weight and size are summarized
in Table 2.  The only statistically significant change in tumor weight was observed at the
1.6mg/ml dosage level in males (56%)(t =1.10 p = 0.02).  The other dosages yielded
relatively the same degree of tumor weight loss in both the males and females (25-38%);
these changes, however, were found to be statistically insignificant.  All of the dosages of
quercetin produced statistically significant decreases in tumor size.  Tumor sizes in the
males showed similar decreases (37-45%)(0.4 mg, t = 1.58, p< .001; 0.8 mg, t = 1.73, p<
.002; 1.6 mg, t = 1.50, p< .001)  while the females showed similar but slightly higher
decreases (36-50%)(0.4 mg, t = 1.40, p< .001; 0.8 mg, t = 1.85, p< .002; 1.6 mg, t = 1.43,
p< .001)  in tumor size.
Figure 7 depicts the histological features in the autopsied tumors.  In the alcohol-
treated (Figure A) control sections, the tumor cells appear to be homogeneously
distributed throughout the tissue without of deterioration or increased vascularity.  As
shown in Figure 8B, some of the cells, from 0.4mg/ml treated tumors, appear to be

































































































































 Mean Wt.       Length x Width





5 Alcohol-sham 2.488 0.92 0% 2.74 0.60 0%
5 0.4mg/ml 1.876 0.32 25% 1.58 0.32 42%***
5 0.8mg/ml 1.73 0.4475 30% 1.73 0.43 37%**
4 1.6mg/ml 1.1025 0.2125 56%* 1.50 0.68 45%***
 
∗%∆ = T - C x 100
C 
B. Females
Mean Wt.       Length x Width
n Dosage grams SEM [%∆] cm2 SEM [%∆]
5 Alcohol-sham 2.232 0.87 0% 2.87 0.54 0%
5 0.4mg/ml 1.448 0.32 35% 1.40 0.43 51%***
5 0.8mg/ml 1.374 0.4475 38% 1.85 0.62 36%**
4 1.6mg/ml 1.55 0.2125 31% 1.43 0.55 50%***
 %∆ = T - C x 100
C 
Statistical significance determined by a two tailed T test
* Statistically significant @ p<.02
* Statistically significant @ p<.002
* Statistically significant @ p<.001
Table 2  Summary of the effects of quercetin on mean Colon-25 tumor  
 weight and size at day 20 post-implantation in Balb-c mice.
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              A. Ethanol                                                                 B. 0.4mg/ml Quercetin
    C.  0.8mg/ml Quercetin                                                        D. 1.6mg/ml Quercetin
Figure 7.  Effects of quercetin on the histology of autopsied Colon-25 tumors in Balb-c
                 mice (x 100 Eosin-hematoxylin).
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photomicrograph, Figure 8C, shows a section from tumors from the 0.8mg/ml quercetin
treated animals.  The cells in this section appear less homogeneously distributed and there
is evidence of crevicing in the tissues.  In the section of the tumor taken from mice
receiving 1.6mg.ml quercetin (Figure 8D), the cells appear to be distributed in clusters
and individual cells appear slightly enlarged with an increase in cell density (nuclear
condensation?).  In general, it was difficult to find any clear, well defined, differences
between the histology of the sections of the treated and untreated tissues.
   The effects of quercetin on the differential leukocyte counts are summarized in
Table 4.  The data show the change in the count/100 cells examined between the first day
of implantation (T0) to the 20
th day post-implantation (T20).  Due to the paucity in the
numbers of monocytes and basophils, it was difficult to establish statistical significance
to the small changes that were observed.  Interestingly, at day T20 there was observed
distinct neutrophilia concomitantly with a distinct lymphopenia in all of the quercetin
treated mice.  The changes were statistically significant but were less pronounced at the
highest dose level (1.6mg/ml).
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Dosage  
Sham  To T20
n mean SEM mean SEM %∆
2 Neutrophils 19 1 15.5 5.5 -18%
2 Lymphocytes 74 4.5 72.5 2.5 -2%
2 Monocytes 5 3 2.5 1.5 -50%
2 Basophils 2.5 0.5 0 0 -100%
0.4mg/ml
9 Neutrophils 19 1 61.9 18.6 229%***
9 Lymphocytes 74 4.5 32.1 17.5 57%*
9 Monocytes 5 3 4.1 2.4 -18%
9 Basophils 2.5 0.5 2.3 0.6 -9%
0.8mg/ml
7 Neutrophils 19 1 57 19.0 200%*
7 Lymphocytes 74 4.5 36 21.1 51%*
7 Monocytes 5 3 4 1.1 -29%
7 Basophils 2.5 0.5 4 1.6 60%
1.6mg/ml
5 Neutrophils 19 1 33.4 4.7 76*
5 Lymphocytes 74 4.5 50.2 5.4 -32%
5 Monocytes 5 3 10.6 7.8 112%
5 Basophils 2.5 0.5 5.2 2.2 108%
* %∆ = T20 - T0 x 100
To 
*p<.02, **p.002, ***p<.001 To= initial count
Statistical significance determined by a two tailed T test T20= count at day 20 
       post-implantation
Table 3  Summary of the effects of oral Quercetin on the mean WBC differential counts in Balb-c 




Three technical problems were encountered in this study: (1) the use of absolute
ethanol as the solvent for the quercetin test solutions (2) the bioavailability of the
quercetin given orally and (3) quantitation of the implants used.
Since the form of quercetin used was hydrophobic, it was necessary to use an
established organic solvent ethanol.  It was found that the tumor growth rates in the EtOH
injected mice were almost identical to those receiving water only, indicating the absence
of a separate EtOH action.
In regard to quercetins bioavailability, the data are conflicting.  In 1975 Gugler et
al. found no measurable plasma concentration following oral administration of 4 grams of
quercetin (Gugler et al. 1975).  However, in 1995,  Hollman reported that up to 24% of
quercetin is absorbed in healthy human ileostomy volunteers.  Probably the most relevant
research came from Ueno et al. (1983).  Through radioactive labeling, they were able to
demonstrate the presence of quercetin in the liver, kidney, and blood, six hours after oral
administration.  They concluded that rats absorb approximately 20% of an oral dose, so it
is probable that quercetin is also absorbed in mice.  It is known that red wine, which is
known to be high in quercetin, decreases ones chance of developing cancer; the
possibility exists that an alcohol solution may enhance quercetins absorption in the
stomach.
To accurately quantify the amount of tumor implant, a grid was fixed underneath
a Petri dish (Figure 1A) so that 4mm x 4mm sections (brei) could be measured and
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implanted changes in tumor size (l x w) were measured daily with calipers following the
first day of palpation, until the 20th day of post-implantation recorded in cm2.
It was difficult to compare the results of this in vivo study with other in vitro
studies which predominate the literature.  However, several in vitro studies demonstrated
growth inhibition of 50% or better in several cancer cell lines.  Quercetin has been shown
to inhibit leukemia and Ehrlich ascites tumors (Suolinna et al.1975), gastric (Yoshida et
al.1990), and colon cancer (Hosokawa et al.1990) among other cell lines in vitro (Avila et
al.1994).  The data presented here support the in vitro studies, and suggest the presence of
antitumor properties of quercetin on intact tumors in whole mammals.
What are the possible mechanisms involved with the anti-tumor actions of
quercetin?   Tumors require an increase in blood vessel vasculature (angiogenesis) in
order to grow past 1-2 mm3 (Folkman 1990).  Quercetin, like Folkmans angiostatin,
has been shown to interfere with angiogenesis in mice (Teicher et al. 1991).  Quercetin is
reported to do this by blocking enzymes at the membrane surfaces that are involved with
the initial steps in angiogenesis (Levi et al. 1984).
In addition to a blood supply, tumors require optimal pH and cannot survive at a
pH lower than 6.0 (Dobrowsky et al. 1991).  Quercetin has been shown to inhibit lactic
acid transport out of colon carcinoma cells, thereby lowering the intracellular pH (Agullo
et al. 1994).
Heat shock proteins (HSP) protect cells against high temperatures as well as other
stresses including radiation and chemical (Boik 1995).  Quercetin has been shown to
inhibit HSP induction in erythroleukaemia cells (Giuliano and Gabriella 1994) rendering
cancer cells vulnerable to radiation and chemical treatment.  Quercetin has also been used
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in combination with radiation therapy, and protects the bone marrow of mice from
radiation injury (Indap et al.1998).  Quercetin, like other antioxidants, scavenges for free
radicals which are often produced through radiation therapy, and have been known to
cause tissue damage.
Quercetin has also been shown to be complementary to chemotherapy by
inhibiting the expression of the multidrug resistance gene MDR1 in human carcinoma
cells (Kioka et al. 1992).  In addition to the MDR1 gene, quercetin has been shown to
inhibit the mutant p53 gene in human breast cancer cell line MDA-MB468 (Avila et
al.1994).  The normal functioning p53 gene is known to trigger apoptosis in the
controlling cell cycle; malfunctioning of this gene has been linked to neoplasmic growth
(Finnegan et al. 1994).
Many researchers now believe apoptosis to be a second type of cell death that is
completely different from necrotic death.  Unlike necrosis, apoptosis affects scattered,
individual cells, does not produce inflammation, and thus does not damage adjacent
normal cells.  Apoptosis, therefore, is thought to represent a mechanism for removal of
old, damaged cells in tumors.  Perhaps, one cause of cancer is due to the failure of
apoptosis to remove cells whose DNA has been damaged (Carson and Riberio 1993).
Such failure might allow the pre-cancerous cell to progress from the initial stage of tumor
production where the DNA damage is reversible to the proliferation stage where the
DNA damage is permanent.  It would seem that under some conditions of DNA damage;
according to Schwartzman and Cidlowski 1993, Meyn et al. 1994 the cells may undergo
apoptosis, rather than live to produce harmful mutations.  There is some evidence that
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certain cytotoxic anticancer drugs induce necrosis at high doses and apoptosis at low
doses (Boik 1995).
Apoptosis, in which cells in effect commit suicide, has been observed in several
in vitro experiments involving quercetin.  The tell-tale signs of apoptosis include:
morphological changes, loss of cell viability, and suppression of cellular progression
through the mitotic cell cycle. In 1994, Wei et al.found morphological changes,
condensation of the nuclear chromatin, and nuclear fragmentation in K562, Molt-4, Raji,
and MCAS tumor cell lines treated with quercetin (Wei et al. 1994).  Indap further
confirmed Weis work in 1997, when quercetin was reported to produce apoptosis in a
dose-dependent manner with characteristic morphological changes such as membrane
blebbing, nuclear condensation, and nuclear fragmentation (Indap et al.1997).  The
nuclear fragmentation can be explained by quercetins ability to actually produce DNA
strand breakage (Rahman et al.1992).  Although the histological micrographs in this
study did not reveal any signs of overt necrosis, evidence of nuclear swelling and/or
nuclear condensation in quercetin treated animals was observed (Figures 8 B,C, & D).
Thus, it may be that apoptosis was occurring in these tumors.  Moreover, the observation
that the quercetin-treated tumors grew at a slower rate, may indicate some kind of
apoptopic action of quercetin.
Quercetins actions on the general mitotic cycle (see below) have been reported
by several workers (Havsteen 1983 and Yosida et al. 1990).  Glycolysis is very important
in dividing cells.  It provides the energy in the form of ATP that the cells need to survive.
Quercetin has been shown to inhibit the glycolytic pathway, in effect reducing a cells
ATP supply (Suolinna et al.1975).  This may be due, in part, to quercetins selective
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inhibition of certain glycolytic enzymes (lactate dehydrogenase and pyruvate
kinase)(Grisiola et al.1975).  In fact, quercetin was shown to be a competitive inhibitor of
G type casein kinase and exhibited a high affinity for the ATP site of the enzyme (Cochet
et al.1982).
Although the data presented do not reveal the precise mechanism(s) involved in
quercetin action, one cannot deny quercetins effect on tumor growth in vivo. While a
dose-dependence action was not evident in the data presented here, quercetins general
effect was a significant (50%) reduction in tumor size (area).  With such dramatic change
in tumor size, one would have expected a similar decrease in tumor weight; however, the
only significant case was in males treated with 1.6 mg/ml of quercetin which
demonstrated a 56% reduction in weight.  This observation might be due to the
differences in the overall tissue constituents of the excised tumors (water vs. organic
matrix).
One interesting observation in this study was a noticeable increase in the
neutrophil count (neutrophilia) concomitant with a drop in the leukocyte count
(lymphopenia) at 20 days post-implantation.  This phenomenon was observed in previous
unpublished experiments carried out by this lab.  This neutrophilia has been observed
in other Balb-c mice with mammary adenocarcinoma (Musiani et al. 1996).  The drop in
leukocyte count may be explained by quercetins role as an antioxidant.  Antioxidants,
which are free radical scavengers, have been shown to decrease rat lymphocytes in vitro
(Pignol et al. 1988).
In summary, the data in this study show that: (1) certain dosages of quercetin in
alcohol solutions, reduce the growth rate, the weight, and the size of implanted Colon-25
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tumors in Balb-c mice (2) these same dosages of quercetin all produce a profound
neutrophilia combined with a significant lymphopenia at day 20 post-implantation and
(3) there was relatively little evidence of significant histological changes in the quercetin-
treated tumor sections, suggesting that the action(s) of quercetin is primarily at the
subcellular level probably within the nuclei of the tumor cells.
Finally, according to Boik (1995) there are more than 135 different glycosides of
quercetin remaining to be tested.  The current study is being extended to include two of
them quercetin-chalcone and quercetin pectin.  The findings of this study suggest a clear
need for a continued study of quercetin and the feasibility of it being a useful adjunct in
certain cancer therapy protocols.
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